Company intelligence / Profile preview

CEERAM Biotech

F-69280, France

Ownership: Private
Development stage: Other

Overview

CEERAM was a French company specializing in the development and manufacturing of real-time RT-PCR detection kits for viral and parasitic pathogens, primarily for food safety testing. It developed the CEERAMTOOLS® platform and offered a range of commercial diagnostic kits for applications such as soft fruit, vegetables, bottled water, shellfish, and environmental surfaces. The company was acquired by bioMérieux in January 2015.

Therapeutic areas: Other
Modalities: Real-time RT-PCR detection kitsPCR-based diagnostics
Industry: Molecular Diagnostics

Partnerships

Life Technologies Corporation (global distribution partnership for food safety products)

Beyond the preview

Go deeper on CEERAM Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEERAM Biotech.

Explore the full profile